Brooke-spiegler syndrome associated with ulcerative rectosigmoiditis

Acta Dermato-Venereologica

Volumn 93, Issue 1, 2013, Pages 112-113

  Peltonen, Sirkku ^a,b   Kankuri Tammilehto, Minna ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADENOID CYSTIC CARCINOMA; ADULT; AUTOSOMAL DOMINANT DISORDER; BIOPSY; BROOKE SYNDROME; CASE REPORT; COLONOSCOPY; DISEASE ASSOCIATION; ENTERITIS; FACE TUMOR; FEMALE; GENE MUTATION; HIDRADENOMA; HISTOLOGY; HUMAN; LETTER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCALP TUMOR; SEQUENCE ANALYSIS; SKIN APPENDAGE DISEASE; ULCERATIVE RECTOSIGMOIDITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MESALAMINE; NEOPLASTIC SYNDROMES, HEREDITARY; PROCTOCOLITIS; SKIN NEOPLASMS;

EID: 84871700633     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1391     Document Type: Letter

References (14)

1. Brooke HG. Epithelioma adenoides cysticum. Br J Dermatol 1892; 4: 269-287.
2. Spiegler E. Ueber endotheliome der Haut. Arch Derm Syph 1899; 50: 163-176.
3. Scheinfeld N, Hu G, Gill M, Austin C, Celebi JT. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome. Exp Dermatol 2003; 28: 539-541.
4. Rajan N, Langtry JA, Ashworth A, Roberts C, Chapman P, Burn J, Trainer AH. Tumour mapping in 2 large multige-nerational families with CYLD mutations: implications for disease management and tumour induction. Arch Dermatol 2009; 145: 1277-1284.
5. Welch JP, Wells RS, Kerr CB. Ancell-Spiegler cylindromas (turban tumours) and Brooke-Fordyce Trichoepitheliomas: evidence for a single genetic entity. J Med Genet 1968; 5: 29-35.
6. Bowen, S, Gill M, Lee Da, Fisher G, Geronemus RG, Vasquez ME, et al. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol 2005; 124: 919-920.
7. Lopiccolo MC, Sage RJ, Kouba DJ. Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study. Dermatol Surg 2011; 37: 1047-1050.
8. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Bar-foot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160-165.
9. Blake PW, Toro JR. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat 2009; 30: 1025-1036.
10. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003; 424: 797-801.
11. Zhang J, Stirling B, Temmerman ST, Ma Ca, Fuss IJ, Derry JM, Jain A. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumourigenesis in CYLD-deficient mice. J Clin Invest 2006; 116: 3042-3049.
12. Costello CM, Mah N, Häsler R, rosenstiel P, Waetzig GH, Hahn A, et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNa microarrays. PLoS Med 2005; 2: e199.
13. Jungehülsing M, Wagner M, Damm M. Turban tumour with involvement of the parotid gland. J Laryngol Otol 1999; 113: 779-783.
14. Cleynen I, Jüni P, Bekkering GE, Nüesch E, Mendes CT, Schmied S, et al. Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS One 2011; 6: e24106.